Lower serum CA125 level, negative vascular invasion, and wild BRAF were strongly associated with better 2-year disease-free survival in patients with stage III colorectal cancer who received adjuvant chemotherapy.

Chang, Shu-Jian; Ge, Xiao-Song; Xu, Zhen-Yu; Qi, Xiao-Wei; Chen, Xiao-Ping

Chang, Shu-Jian; Ge, Xiao-Song; Xu, Zhen-Yu; Qi, Xiao-Wei; Chen, Xiao-Ping.

Afiliação

Chang SJ; Department of Oncology, Affiliated Hospital of Jiangnan University, Wuxi 214062, Jiangsu, China.
Ge XS; Department of Oncology, Affiliated Hospital of Jiangnan University, Wuxi 214062, Jiangsu, China.
Xu ZY; Department of Oncology, Affiliated Hospital of Jiangnan University, Wuxi 214062, Jiangsu, China.
Qi XW; Department of Pathology, Affiliated Hospital of Jiangnan University, Wuxi 214062, Jiangsu, China.
Chen XP; Department of Oncology, Affiliated Hospital of Jiangnan University, Wuxi 214062, Jiangsu, China.

Cancer Biomark ; 22(1): 161-168, 2018.

Article em En | MEDLINE | ID: mdl-29562502

Assuntos

Antígeno Ca-125/sangue; Neoplasias Colorretais/sangue; Proteínas Proto-Oncogênicas B-raf/genética; Idoso; Quimioterapia Adjuvante; Neoplasias Colorretais/tratamento farmacológico; Neoplasias Colorretais/genética; Neoplasias Colorretais/mortalidade; Intervalo Livre de Doença; Feminino; Humanos; Masculino; Estadiamento de Neoplasias; Taxa de Sobrevida; Fatores de Tempo

Palavras-chave

BRAF; CA125; adjuvant chemotherapy; colorectal cancer; vascular invasion

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Antígeno Ca-125 / Proteínas Proto-Oncogênicas B-raf Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male Idioma: En Revista: Cancer Biomark Assunto da revista: BIOQUIMICA / NEOPLASIAS Ano de publicação: 2018 Tipo de documento: Article País de afiliação: China

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google